Form 4: AngioDynamics EVP and CFO Stephen Trowbridge Reports Stock Disposals for Tax Obligations

Stephen Trowbridge, EVP and CFO of AngioDynamics, reports the disposal of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Stephen A. Trowbridge, the EVP and CFO of AngioDynamics Inc., filed a Form 4 on July 25, 2024, reporting changes in beneficial ownership.
• The report details the disposal of 717 shares of common stock on July 20, 2024, at a price of $7.13 per share to satisfy tax withholding obligations related to vesting restricted stock units granted on July 20, 2022.
• Additionally, 667 shares were disposed of on July 21, 2024, at $7.13 per share for similar tax obligations related to restricted stock units granted on July 21, 2021.
• Following these transactions, Trowbridge directly owns 166,470 shares of AngioDynamics common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing relates to routine stock disposals for tax purposes and doesn't indicate any fundamental change in the company's prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The stock disposal has a minimal impact on shareholders as it is related to tax obligations and doesn't reflect a change in the executive's long-term outlook on the company.

Key Dates